Latest News on Crohn’s Disease
5/21/2004
Crohn’s disease is a type of inflammatory bowel disease (IBD) and about one out of every six patients with IBD also has spinal inflammation. When the entire spine is involved, this is AS. Thus, some patients with AS also suffer from Crohn’s. As of late, there have been many studies on Crohn’s disease and below are links to articles/studies to the most recent of them.
Cross-sectional Imaging in Crohn Disease
The role of cross-sectional imaging in the diagnosis of Crohn disease has expanded with recent technologic advances in computed tomography (CT) and magnetic resonance (MR) imaging that allow rapid acquisition of high-resolution images of the intestines...
Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions
Elan Corporation, plc and Biogen Idec announced that in a Phase III maintenance study, ANTEGREN? (natalizumab) maintained clinical response and remission rates throughout six months among patients with Crohn's disease (CD) who had previously achieved clinical response. Additionally, a majority of natalizumab-treated patients who were also on chronic corticosteroid therapy were able to withdraw from corticosteroids and maintain response in contrast to those patients on placebo...
Abbott Arthritis Drug Helps Crohn's Patients
Abbott Laboratories Inc. on Tuesday released trial data that showed its arthritis drug Humira helped patients with moderate to severely active Crohn's disease achieve remission of the severe bowel disorder. Humira is the first drug since infliximab, a drug that fights inflammation known by the brand name Remicade, to achieve its trial goal of induction of clinical remission in moderate to severely active Crohn's disease in a placebo-controlled trial, Abbott said in a statement...
Research hones in on therapies and diagnosis of bowel diseases
Inflammatory bowel diseases collectively cause significant lifestyle sacrifices and suffering and millions of dollars in related health care costs every year, partially due to a lack of effective diagnostic procedures and therapies. In new studies presented today at Digestive Disease Week in New Orleans, researchers show evidence of accurate and effective new methods for diagnosis, as well as improved treatment options, for sufferers of ulcerative colitis and Crohn's diseases. Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery...
Stay informed
Keep up-to-date on the latest research, treatments and information on AS and related disease with Spondylitis Plus, our magazine that comes FREE with SAA Membership.